HomeNewsManufacturing

Juncell Therapeutics Opens New Manufacturing Facility in China

Juncell Therapeutics Opens New Manufacturing Facility in China
Shanghai Juncell Therapeutics Co. Ltd., a biotech company focused on developing new treatments using Tumor-Infiltrating Lymphocytes (TIL) that don't rely on IL-2, has opened a new manufacturing facility in the Anting International Medical Industry Park in Jiading District, Shanghai, China.
 

The new facility covers more than 16,000 square meters and includes areas for production, quality control, data management, and operations. It is designed to produce enough TIL treatments for 6,000 to 10,000 patients each year. This milestone will help improve the development of high-quality TIL treatments and support the progress of new technologies.

The opening ceremony was attended by officials from the National Development and Reform Commission, Shanghai Municipality, Jiading District, Anting Town, and Anting International Medical Industry Park, as well as representatives from investment groups, clinical experts, and leaders from major companies

Read more on:
More news about: manufacturing | Published by Manvi | December - 20 - 2024

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members